Ultomiris 1,100 MG/11 ML vial 11ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9KR8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,640
Award facts
- Contract value 100% obligated
- $61,640.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $61,640.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Ultomiris (pegcetacoplan) 1,100 mg/11 mL vials. This non-set-aside delivery order will be completed by February 3, 2026, with performance taking place at the awardee's headquarters in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
Ultomiris is a complement inhibitor indicated for treating rare hemolytic conditions and is part of the broader pharmaceutical portfolio that AmerisourceBergen supplies to federal military and healthcare systems. As a leading pharmaceutical distributor, AmerisourceBergen competes on a full and open basis for federal procurement and demonstrates extensive capability in fulfilling government requirements for specialty medications, branded and generic drugs, and other critical medical commodities across multiple therapeutic domains supporting Defense Health Agency programs and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F9KR8?
SPE2DR26F9KR8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F9KR8 worth?
The government has obligated $61,640 on SPE2DR26F9KR8.
Is contract SPE2DR26F9KR8 an order under another contract?
Yes. SPE2DR26F9KR8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KR8 competed?
The extent of competition for SPE2DR26F9KR8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award